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ABSTRACT 
 
The way that soldiers are injured in modern conflicts has changed.  Bullet and 
ballistic weapons are causing fewer casualties, and more commonly Improvised 
Explosive Devices (IED) are injuring them.  The purpose of this thesis is to 
characterize the injury pattern of the antipersonnel IED (AP-IED) in victims from 
the Afghanistan conflict, to retrospectively examine the incidence and type of 
vascular trauma in a Canadian level 1 trauma center and to develop and novel 
device for control of junctional vascular injuries.   
 
The injury pattern of 100 consecutive AP-IED victims was recorded. Multiple 
amputations occurred in 70% of IED victims: 5 quadruple amputations, 27 triple 
amputations, and 38 double amputations. Pelvic fractures occurred in 21 victims 
and severe perineal, gluteal or genital injuries were present in 46 patients. The 
casualty fatality rate was 19%.  
 
All adult trauma patients who presented to a Canadian Level I trauma centre with injuries 
to named arterial or venous vessels from 1 January 2011- 31 December 2015 were 
reviewed. The majority of patients were male (70.1%) with an injury severity score of 15 
or greater in 63.3%. Blunt mechanism accounted for 61.4%.  Vessel injuries to the neck 
(20.4%), thorax (20.4%), abdomen/pelvis (19.7%), upper extremity (24.5%) and 
lower extremity (15.0%) were identified. Prehospital tourniquet use for arterial 
injuries occurred in 12.2%. Non-operative management was used in 39 patients 
(28.3%) and open and endovascular repair were undertaken on 59 (42.8%) and 17 
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(12.3%) respectively. No temporary intravascular shunts or balloon aortic occlusion 
devices were used. Thirteen different subspecialty disciplines managed vascular 
trauma at this centre. 
 
A novel device for the control of pelvic and junctional hemorrhage was developed 
and tested in porcine and human cadavers. Placement of a catheter into the femoral 
vessel was followed by expression of the balloon with inflation by CO2 in a proximal 
direction. Thus it can navigate and treat damaged pelvic vasculature, occluding the 
distal aorta, and is technically simple to use. This CO2 balloon system was tested on 
model aortas with inline fluid flow and pressure monitoring to determine the 
maximum pressure the balloons could occlude.  The device was tested on both intact 
and injured cadaveric porcine aortas for its ability to occlude fluid flow and to test 
the devices safety for use in arteries. The device was tested on a dye-perfused 
human cadaveric model. The results of the study indicate the device can occlude 
fluid flow to supra-physiologic pressures and will rupture before injuring the vessel 
in the event of over inflation. It has the advantage of being able to navigate and treat 
injured pelvic vessels and is easy to use. This device may provide a tool to 
community hospitals and forward medical care providers in managing non-
compressible pelvic hemorrhage. 
Key words:  blast, trauma, vascular injury, improvised explosive device, military. 
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INTRODUCTION 
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CHAPTER 1:  INTRODUCTION  
1.1 Introduction 
Between January 2002 and until March 2014 Canadian soldiers were in Afghanistan, 
first in a combat role fighting the Taliban and al-Qaeda, then in a training role 
preparing the Afghan National Army.  More than 40,000 Canadian soldiers would 
serve in Afghanistan during this conflict and Canada would suffer its first combat 
casualties since the Korean War.  158 Canadian Armed Forces soldiers died 
including Captain Nichola Goddard, the first female Canadian soldier to ever die in 
combat.1 
 
This war presented a change in the way Canadian soldiers were injured. The 
majority of the people injured in this war were not harmed by bullets and 
conventional fighting but by Improvised Explosive Devices (IEDs).2,3 IEDs are 
explosives, either taken from conventional weapons and repurposed, or created de 
novo. They then are detonated either by remote control, a pressure plate, or a trip 
wire to explode and injure or kill their target.  These custom-made bombs may be 
used to attack vehicles, large crowds, or a dismounted soldier walking on patrol.4 
This change in the way our solders are attacked has changed the type of injuries 
treated by our combat hospitals.5-7 
 
In treating these IED casualties combat surgeons needed to become adept at 
vascular damage control surgery.  Canadian surgeons treating trauma patients in 
Kandahar, Afghanistan reported over 100 vascular repairs between 2005 and 
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2010.8 The use of tourniquets, temporary intravascular shunts and aggressive 
vascular ligation became commonplace.  The Afghanistan war changed the way 
military surgeons treat vascular trauma patients.9  
 
Most of the changes in vascular trauma care were made out of necessity and 
adaptations to the casualties the surgeons were receiving.  In order to prospectively 
monitor outcomes the Joint Theatre Trauma Registry was developed.  As these 
deployed surgeons returned home they brought with them their experiences 
managing vascular trauma from combat.  The American Association for the Surgery 
of Trauma (AAST) sponsored the Prospective Observational Vascular Injury 
Treatment Registry (PROOVIT) in order to document changes in treatment of 
American vascular trauma and monitor outcomes. 10 
 
Although much has been published about the medical experience in the Afghanistan 
war there remains several unanswered problems.  What is the medical description 
of the injury pattern of the IED?  Do combat damage control vascular techniques 
apply to a Canadian trauma population? Is there any novel way we can gain 
hemorrhagic control of the vascular trauma injured patient that is fast, safe and easy 
to use? It is the purpose of this thesis to address these three questions. 
 
In order to be able to prepare for combat we must understand the way we are being 
attacked.  In order to be prepared to treat our casualties we must know the nature 
of the injuries they will incur. Although many case series have been published of IED 
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injured patients,5,6,11 there is no prospectively collected definitive description of 
what the injury pattern of the IED casualty is.  The International Committee of the 
Red Cross (ICRC) has established the injury pattern of the conventional 
antipersonnel landmine.12 That work helped with the medical justification for the 
eventual banning of land mines by 162 countries with the Ottawa Treaty in 1999.13 
In order to ensure that physicians and surgeons are adequately prepared to treat 
IED victims, this injury pattern must be described. In order that protective 
equipment for our soldiers can be appropriately developed this injury pattern must 
be described.  Moreover, as a society in order to judge how we view the use of these 
weapons, this injury pattern must be described.  To provide a definitive description 
of the injury pattern of the antipersonnel IED 100 consecutive casualties of this 
weapon had their injuries recorded and described. 
 
In order to implement the lessons learned from treating vascular trauma in 
Afghanistan, as well as to know how to apply the data obtained from American 
prospective registries we must understand the Canadian incidence and description 
of vascular trauma as well as what our current practice patterns are. Who treats 
vascular trauma in Canada? What injuries do they encounter and how do they treat 
them?  The differences in the mechanism of injury, as well as the trauma system 
receiving the patient, may be important in determining what changes in practice 
Canadian trauma systems should adopt.  Given that Canadian trauma patients are 
less likely to be injured by an IED or an assault rifle, how should we use the 
information gained from wartime experiences?  How does Canadian vascular 
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trauma differ from that found in Afghanistan or the United States? To answer this 
question, we conducted a retrospective cohort study evaluating all patients with 
traumatic vascular injuries over a five year period at London Health Sciences Center 
(LHSC), a Canadian level 1 trauma center.   
 
With the advent of Tactical Combat Casualty Care (TCCC) and personal protective 
equipment (PPE) more soldiers are being treated for, and surviving, potentially 
preventable causes of death on the battlefield.14 However, IEDs can cause junctional 
vascular injury and non-compressible torso hemorrhage not amenable to tourniquet 
application of TCCC techniques.15 This has caused an interest in Resuscitative 
Endovascular Balloon Occlusion of the Aorta (REBOA) with the publication of a Joint 
Trauma System Clinical Practice Guideline for the use of REBOA16 . However many 
REBOA techniques require two meter endovascular wires and 12 French (Fr) 
sheathes that preclude this technique from being adopted in a forward medical 
environment. Where REBOA portends great theoretical advantage is in the 
evacuation of combat casualties from the point of injury to surgical care. Morrison et 
al.’s analysis of the UK joint trauma registry over a ten-year period identified 174 
deaths that had indications for REBOA. One hundred forty-five of these patients died 
before reaching hospital (83%), with a mean time to death of 75 minutes. The 
authors suggested that REBOA could act as en route hemorrhage control to get these 
casualties to a surgeon; as many as 18% of modern combat casualties may benefit 
from REBOA treatment 17. We have designed a novel device that does not require 
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long endovascular wires and would be more amenable to insertion into injured 
junctional vessels.   
 
In this thesis, the injury patter of the antipersonnel IED (AP-IED) has been 
described.  A Canadian Level I trauma centre cohort of vascular trauma patients has 
been described to help guide implementation of the lessons learned from treating 
combat vascular trauma patients and American registries.  Finally, a novel device to 
treating the junctional and non-compressible vascular injures has been developed 
and tested.  Given the change in the way solders are injured in combat and the 
significance this has on the type of injury being treated, the first aim of this study is 
to determine the combat injury pattern caused by IED versus previous bullet or 
APM casualties.  Secondly, if the type of injury has changed, then both the training to 
deal with this trauma needs to be characterized and suitability of interventional 
devices needs to be explored.  The latter aim will be addressed by defining how 
Canadian Level I trauma centres deal with vascular injuries and proposing a novel 
device to treat non-compressible vascular injuries in combat situations or local 
communities. This current body of work further characterizes combat vascular 
trauma and proposes an innovative treatment option. In this thesis, combat vascular 
trauma has been taken from characterization to innovation. 
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CHAPTER 2: INJURY PROFILE SUFFERED BY TARGETS OF THE 
ANTIPERSONNEL IMPROVISED EXPLOSIVE DEVICE 
2.1 INTRODUCTION 
Antipersonnel mines (APM) came into widespread use in the Second World War.  
Originally they were used to protect anti-tank mines, but then went on to become a 
weapon system in and of themselves. They were designed to injure but not kill, in 
order to remove a target from combat and to increase the logistical burden of caring 
for the casualty. These weapons are typically buried and left for the target to trigger. 
The weapon is indiscriminate because non-combatants such as children and 
civilians may detonate them. They are also frequently left buried and active after 
fighting in that region, or the conflict itself, has ended. Following a public relations 
campaign that highlighted the indiscriminate injuries caused by APMs, 162 
countries signed the 1999 Ottawa treaty ceasing their production and use.1 An 
important basis of that campaign was the clinical description of APM related injuries 
by Robin Coupland and Adriaan Korver for the International Committee of the Red 
Cross (ICRC).2 Three patterns of injury were found among 754 victims treated at 
two ICRC hospitals following wounding by blast or fragmentation mines. In pattern 
1 injuries, the victim triggers a blast mine by stepping on it and suffers the full effect 
of the explosion. In pattern 2 injuries, victims are farther away from the centre of 
the explosion, whether it is a blast or fragmentation mine, and suffer wounds from 
fragments. Pattern 3 injuries are caused by handling the mine (blast or 
fragmentation), resulting in severe injuries to the hands and possibly the face and 
chest. Pattern 1 victims suffer one or more traumatic amputations of the lower limb, 
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whereas pattern 2 victims have fragment wounds scattered over the body. Pattern 2 
victims may have fragment injuries of the lower limbs but the damage is not severe 
enough to cause traumatic amputation. 
 
This distinguishing feature of a traumatic amputation between pattern 1 and 
pattern 2 injuries was confirmed in a later report of 4616 APM victims which 
presented further evidence of the severity of injury particularly to the limbs.3  Of 
1077 (23%) pattern 1 victims, 606 (56%) had below knee amputation (BKA), 26 
(2%) bilateral BKA, 349  (32%) unilateral above the knee amputations (AKA), 57  
(5%) bilateral AKA, and 39 (4%) a combination of AKA and BKA.3  Their description 
of the typical pattern 1 injury profile caused by an APM, which has been confirmed 
by other studies, is of a traumatic amputation of the foot or leg with scattered 
penetrating injuries elsewhere. 2-5 
 
The improvised explosive device (IED) is increasingly used in modern conflicts 
including Afghanistan.6,7 The majority of these weapons have been directed against 
pedestrian individuals in a similar fashion to APM.8,9  As with APM, injuries suffered 
by victims of the anti-personnel IED (AP-IED) depend on whether they were the 
target of the explosive device or at some distance from the centre of the explosion. It 
does not depend on the manufacture of the explosive device, industrial as in APM 
versus improvised as in AP-IED. Indeed elements of conventional explosives may be 
used to construct an AP-IED. The blast injury depends on the energy transferred by 
the explosion to the victim. However it was our impression that pattern 1 injuries 
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caused by AP-IED were significantly worse than those reported for APM.2 The 
purpose of this paper is to describe the profile of pattern 1 injury suffered by the 
target of the AP-IED compared to the target of APM. 
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2.2 METHODS 
The cohort of patients under study was defined as those pedestrian victims of an AP-
IED who suffered a traumatic amputation. In order to be included in the study, 
casualties were required to have been reported by the first responder as being the 
dismounted (pedestrian) victim of an IED explosion and to have suffered a traumatic 
amputation. Casualties that were non-pedestrian (i.e. in a vehicle) or whose 
situation was unknown were excluded. The study was designed to describe the 
injuries suffered by 100 consecutive targets of AP-IED attacks who presented to the 
North Atlantic Treaty Organization Role 3 Multinational Medical Unit (R3-MMU) in 
Kandahar Air Field (KAF). The hospital received casualties from the point of injury 
or via a forward treatment centre.10 A R3-MMU is the highest level of in-theatre 
medical care and would be equivalent to a civilian level-II trauma centre, as defined 
by the American College of Surgeons Committee On Trauma. A specifically 
designated trauma nurse (M.D.), and attending surgeons (J.T., V.M.) prospectively 
collected data for each patient. Data was collected between January 2010 and July 
2011, or until data from 100 victims had been obtained. Data collected included: 
nationality, age, gender, mortality status, specific injuries, and imaging results. The 
level of traumatic amputation, the level of soft tissue injury, the fracture pattern 
(including pelvic fractures) as well as perineal and gluteal injuries were specifically 
recorded. Generally, coalition patients were transferred after damage control 
surgery, whereas local patients also received definitive care at the R3-MMU. Data 
were collected until the time of first discharge from the hospital. In order to 
minimize bias, patients were included sequentially as a consecutive series with a 
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predefined definition of AP-IED target. The R3-MMU was the only surgical facility in 
the region and would receive all AP-IED victims for care. Patient level data is 
reported identifying the injuries of each of the 100 victims. The paediatric victims 
are also presented separately. The data collection was complete with injury data 
captured for all 100 victims. Categorical data was analysed using the chi-square test. 
AP-IED data was compared to previously published APM data2. This study was 
approved by the commander of the R3-MMU KAF and by the Research Ethics Board 
of the University of Western Ontario (REB # 104124).  
 
2.3 RESULTS 
One hundred consecutive casualties with amputations from AP-IEDs were identified 
and their injuries were described. All of the patients were male. The mean, and 
median, age of the victims was 25 years.  The age range was from ages 6 to 44 years. 
There were 9 patients under the age of 18 (Figure 2.1).  Twenty-seven patients were 
Afghan local nationals and 61 were coalition soldiers (USA, Canada, UK); there were 
12 victims whose nationality was not captured (Table 2.1).  Eleven patients were 
dead upon arrival and another 8 died of their wounds in the hospital, giving a 19% 
casualty fatality rate. Gender, injury pattern, and age or approximate age, was 
recorded for all victims.  
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Figure 2.1 Victim ages 
 
Table 2.1 Victim characteristics 
 
Characteristic  
Number of patients  100 
  
Age, mean (SD) 25 (6.8) yrs 
  Median 25 yrs 
  Range 6 – 44 yrs 
  
Male 100  
Female 0  
 
Nationality 
 
     Afghan 27  
    
     Coalition 
        American 
        Canadian 
        UK  
    
     Not specified 
  
61 
49 
8 
4 
 
12 
  
  
Mortality 
   Killed in Action 
   Died of wounds 
19 
11 
8  
  
 
SD = standard deviation 
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AP-IED victims were more likely than a similar cohort of APM victims to suffer 
multiple amputations (70.0% vs. 10.4%; p<0.001) or genital injury (26.0% vs. 
13.4%; p=0.007). Seventy victims (70%) sustained multiple amputations: 5 patients 
suffered quadruple amputations, 27 had triple amputations, and 38 victims had 
double amputations (Figure 2.2). Two victims had hip disarticulations, 41 had at 
least one AKA, and 56 had at least one BKA (including through knee and through 
ankle amputations).  Sixty-five victims had bilateral lower extremity amputations 
and 37 had at least one upper extremity amputation (at the level of the hand or 
higher) (Table 2.2). Pelvic fractures were present in 21 victims, all but one of whom 
had multiple amputations.  Forty-six patients had perineal and gluteal injuries; these 
included 8 anorectal injuries, 8 penile injuries, and 26 scrotal injuries including 10 
orchiectomies. There were 13 facial injuries, 9 skull fractures and 3 traumatic brain 
injuries. Eye injuries were found in 11 patients, none of whom were wearing eye 
protection. Of the 9 paediatric patients, 3 had triple amputations and 5 had double 
amputations. There was one pelvic fracture and two perineal injuries among the 
paediatric victims (Table 2.3). Pelvic fracture was more likely if the victim had 
multiple amputations (28.6% vs. 3.3%; p=0.005) or had a perineal or gluteal injury 
(32.6% vs. 11.1%; p=0.009). Those victims with multiple amputations also had more 
perineal and gluteal injuries (52.9% vs. 30%; p=0.036) and a higher mortality 
(24.3% vs. 6.7%; p=0.039).  
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Figure 2.2: Number of amputations per victim 
 
 
Figure 2.3 
 
 
X-ray taken for placement of a pelvic external fixator showing: disruption of pelvic 
ring by the force of an anti-personnel improvised explosive device; combat gauze 
packing a severe perineal injury; silica laden soil injection by the explosion. 
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Table 2.2 Distribution of amputations 
 
Amputation Type Overall Pelvic 
Fracture 
Perineal
, Gluteal, 
Genital 
Injury 
Killed 
in 
Action 
Died of 
Wounds 
Casualty 
Fatality 
Rate 
HipDis/TKA/UEA 1 0 0 0 1 1/1 
HipDis/- 1 0 0 0 1 1/1 
AKA/AKA/UEA/UEA 4 0 3 0 0 0/4 
AKA/AKA/UEA 7 3 6 0 0 0/7 
AKA/AKA 8 2 4 2 1 3/8 
AKA/BKA/UEA 2 1 0 1 1 2/2 
AKA/TKA/UEA 1 1 0 0 1 1/1 
AKA/BKA 7 1 5 0 0 0/7 
AKA/TKA 7 4 6 0 0 0/7 
AKA/UEA/UEA 1 0 0 0 0 0/1 
AKA/UEA 1 0 0 0 0 0/1 
AKA/TAA 1 0 0 0 0 0/1 
AKA/- 2 0 0 0 0 0/2 
BKA/BKA/UEA/UEA 1 0 0 0 1 1/1 
BKA/BKA/UEA 13 4 6 4 2 6/13 
BKA/TKA/UEA 1 0 1 0 0 0/1 
BKA/BKA 9 3 5 2 0 2/9 
BKA/UEA 2 0 0 0 0 0/2 
BKA/TKA 1 0 0 1 0 1/1 
BKA/- 22 1 9 1 0 1/22 
TKA/TKA/UEA 1 1 1 0 0 0/1 
TKA/TKA 1 0 0 0 0 0/1 
TKA/- 1 0 0 0 0 0/1 
TAA/UEA 1 0 0 0 0 0/1 
TAA/- 3 0 0 0 0 0/3 
UEA/- 1 0 0 0 0 0/1 
       
 
HipDis, hip disarticulation; AKA, above knee amputation; BKA, below knee amputation; 
TKA, though knee amputation, TAA, though ankle amputation; UEA, upper extremity 
amputation, which includes above elbow, below elbow and hand amputations. 
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Table 2.3 Distribution of paediatric amputations 
 
Age (Years) Amputation Type Pelvic 
Fracture 
Perineal, 
Gluteal, 
Genital 
Injury 
Disposition 
16 AKA/BKA No No Survived 
14 AKA/AKA No Yes DOW 
14 AKA/UEA/UEA No No Survived 
11 UEA/TKA/AKA Yes No DOW 
10 BKA/BKA/UEA No No KIA 
10 UEA/TAA No No Survived 
10 BKA/AKA No Yes Survived 
10 BKA/BKA No No KIA 
6 UEA No No Survived 
 
Therefore, the typical injury profile suffered by targeted victims of AP-IEDs 
included: bilateral lower extremity amputations (often above the knee); mangling or 
amputation of an upper extremity; extensive soft tissue injury with deep 
contamination by soil, extending into gluteal and perineal regions; pelvic ring 
disruption and genital mutilation.  
2.4 DISCUSSION 
The mechanism of injury is the same for all anti-personnel explosive devices. The 
severity of injury depends upon the energy transferred by the explosion to the 
victim. There is nothing inherently different between the APM and the AP-IED. 
Indeed the AP-IED might be considered a subset of APM. However, the comparison 
in this study is between the conventional blast APM, industrially manufactured for 
national armies and the AP-IED, that were manufactured locally from available 
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materials and used in the recent conflict in Afghanistan. Coupland and Korver 
believed they were dealing with the former device.2,3,4 In a textbook reflecting on the 
Russian experience in Afghanistan, Bruysov and colleagues illustrated the 
mechanism of injury from the conventional blast APM in a series of experiments 
using rapid sequence photography which confirmed Coupland and Korver's 
description of a foot amputation with scattered penetrating injuries elsewhere.11 
The AP-IED, sometimes portrayed as a primitive or crude weapon crafted from 
locally available resources because of a lack of access to conventional weapons, has 
evolved with use in different conflicts. From rudimentary devices of nails in wooden 
boxes used in Cambodia and Columbia, AP-IEDs used in recent conflicts are better 
directed and more destructive. The injury profile from the modern AP-IED is far 
worse than originally described for conventional blast APMs. Whereas the blast APM 
typically results in a unilateral lower limb amputation, the modern AP-IED causes 
bilateral high amputation of the lower extremities. Triple amputations were not 
seen with APM but occurred in 27% of victims of AP-IEDs. Severe perineal and 
gluteal injury with soft tissue contamination with soil was commonly present in the 
victims of the AP-IED but is not seen among the ICRC experience with APM injured 
patients. 2 The energy transfer endured by targeted victims of AP-IEDs must be far 
greater than that caused by APMs. A measure of the force is the fact that it is 
sufficiently powerful to disrupt the pelvic ring in one fifth of the patients (Figure 
2.3).  
It is not the purpose of this paper to undermine the abhorrence of injuries caused by 
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conventional APMs, which are often devastating and ruin lives. Both the APM and 
AP-IED injure indiscriminately. In this series, almost one in ten victims of AP-IEDs 
was a child, a tragic feature in common with APMs. Even more disconcerting is the 
frequency with which children suffer the severest injuries from the powerful 
explosive force of the AP-IED: 89% suffered multiple amputations and 33% lost 
three limbs.  
The AP-IED victims wore different types of personal protective equipment (PPE) or 
none at all. Coalition soldiers wore PPE including helmets, body armour, and anti-
ballistic eyewear.  Each nation issued its own style and brand of PPE. Local Afghan 
soldiers often used helmets but their use of body armour was more inconsistent and 
they almost never used ballistic eyewear.  Civilian casualties were not wearing any 
PPE. This heterogeneity of PPE use in our sample may have affected the pattern of 
injury characterized in this study but the sample size was insufficient to determine 
accurately the injury preventative role of PPE. We felt there was a lower than 
expected rate of abdominal, thoracic and eye injuries in victims wearing PPE. We 
also felt that the design purpose of PPE, to prevent fragment injury, was confirmed 
in patients with pattern 2 injuries who are not included in this study.   
It is possible that we have magnified the severity of the injury pattern by 
concentrating our focus upon patients that met our definition of being targeted by 
the AP-IED, that is having sustained at least one limb amputation. It is also possible 
that if a casualty was injured by an unexploded ordinance or classical land mine but 
reported by first responders to have been injured by an AP-IED they may have been 
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erroneously included. However our findings are in keeping with other descriptions 
of IED injuries in the literature. Jacobs et al. classified the limb injury pattern of 103 
consecutive casualties of IEDs treated at a UK Role 3 facility in Helmand Province, 
Afghanistan.12 They included victims who did not have amputation of a limb. They 
found 76 victims suffered significant bilateral lower limb injuries, with 50 who 
required bilateral lower limb amputation. Thirty-three victims suffered genital or 
perineal injury, 9 sustained pelvic ring disruption, and 40 sustained significant 
upper limb injury. They found that all pelvic fractures and 80% of genital injuries 
were sustained among casualties with bilateral lower limb amputations.  A 
retrospective review of the UK Joint Theatre Trauma Registry examined UK services 
personnel who were casualties of IEDs in Afghanistan, who sustained lower 
extremity amputations between January 2007 and December 2010.13 This registry 
includes post-mortem reports of soldiers who were killed and never received 
hospital care. The registry is restricted to UK service members and contains no local 
nationals or civilian injuries. They examined 656 IED victims with 138 killed in 
action (21%) and 31 who died of their wounds (4.7%) resulting in a 25.9% casualty 
fatality rate.  Of the 169 victims who sustained a traumatic lower extremity 
amputation, 69 were killed in action (40.8%) and 31 died of their wounds (18.3%). 
They found that the level of amputation was inversely correlated with survival with 
only two survivors from hindquarter amputation out of 39 patients with this level of 
injury. Another retrospective review of the UK Military Trauma Registry focused on 
soldiers from Afghanistan with bilateral leg amputation.8 They examined 43 
casualties with at least two amputations; 80% of these were from AP-IEDs with the 
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other 20% being from anti-vehicle-IEDs.  The most common bilateral amputation 
was a bilateral AKA (58%), and 20% of victims suffered triple amputation. 14% of 
victims sustained open pelvic fractures and 44% suffered perineal or genital injury. 
No victims survived the loss of all four limbs. 
The soft tissue injury is a particularly difficult problem encountered by those caring 
for victims of AP-IEDs. The directed explosion forces soil up along soft tissue planes 
far above the point of entry. This may worsen the level of eventual amputation and it 
condemns the victim to multiple operations to remove the contamination. Even still, 
it may leave the victim at the mercy of unusual antibiotic resistant soil organisms 
such as Acinetobacter baumannii.14 
Knowing the pattern of injury helps responders tailor care. As Jacobs and colleagues 
have suggested, first responders should apply tourniquets bilaterally even if the 
victim is not bleeding, as haemorrhage is likely to start once resuscitation restores 
intravascular volume.12 While current protocols require medics to apply a neck 
collar to all victims of IEDs, spinal injury is rare in AP-IED victims despite the 
magnitude of the force.9 On the other hand, we recommend that all AP-IED victims 
with perineal injuries or multiple amputations have pelvic binders placed by the 
first responders, as both are associated with pelvic fracture. This may reduce the 
large amount of blood that may be lost silently with pelvic disruption. Multiple 
surgical teams have to work simultaneously to rescue these patients. Surgeons have 
to be adept at dealing with pelvic and gluteal bleeding, sometimes by pre-peritoneal 
packing and by ligating the internal iliac artery. Rehabilitation requires mobilization 
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on temporary lower limb prostheses despite injured upper limbs. Finally, victims of 
this severe injury pattern need life-long support because disabilities may become 
more pronounced as the capacity to compensate fades with age.  
In collecting information on 100 consecutive patients, we hope to have described a 
generalizable result. Due to the nature of the conflict and the local culture, all of the 
patients examined were male. While we would expect the severity of the injury 
pattern to be generalizable to females, we cannot explicitly determine the effect of 
the modern AP-IED on the female pelvis and perineum.  
The use of conventional APM has decreased in the last 20 years since the campaign 
to prohibit their use. Pattern 1 injuries seen in recent conflicts are far more often 
from AP-IEDs than conventional APMs. ICRC includes AP-IEDs in its definition of 
APM if the victim triggers the weapon. The injury profile described in this report is 
illustrated in the recent edition of its textbook on war surgery.15 Despite the huge 
force endured by the targeted victim of the AP-IED, the casualty fatality rate that we 
observed was 19%. This rate is an underestimate, as some casualties who were 
killed at the site of the AP-IED may not have been brought to our facility and others 
may have died as a result of injuries after transfer or discharge. Reports regarding 
APM are also affected by this problem. The observed mortality rate with AP-IED is of 
the same order as that elsewhere.15 The injury pattern suffered by the target of the 
AP-IED is markedly worse than that of conventional APM. Pelvic binders and 
tourniquets should be applied at the point of injury to patients with multiple 
amputations or perineal injuries. The AP-IED causes more severe injury than APM. It 
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is a weapon which of its nature causes superfluous injury and unnecessary suffering. 
Just as the reports by Coupland and Korver provided the medical evidence upon 
which the prohibition of conventional APM was based, it is hoped that reports 
regarding the pattern of injury caused by the modern AP-IED will result in an 
abhorrence of this weapon and those who use it.  
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CHAPTER 3:  INCIDENCE AND MANAGEMENT OF VASCULAR TRAUMA: A 
CANADIAN EXPERIENCE 
3.1 Introduction 
 
In the past decade there has been a shift in the therapies and philosophies 
associated with treating vascular trauma.  Damage control resuscitation and the use 
of vascular shunting and tourniquets have become more emphasized 1-4.  Much of 
this evolution has been as a result of findings captured in trauma registries in Iraq 
and Afghanistan 5-7.  Novel technologies have been introduced to temporize the 
exsanguinating vascular trauma patient, including the resuscitative endovascular 
balloon occlusion of the aorta for hemorrhage control (REBOA)8. 
 
In order to describe the state of vascular trauma therapy in the United States, as 
well as to be able to capture long-term outcomes from vascular trauma intervention, 
the American Association for the Surgery of Trauma (AAST) developed a 
Prospective Observational Vascular Injury Treatment Registry (PROOVIT) 9. This 
registry, which is comprised of 14 Level I and Level II trauma centers, has published 
their first year’s findings.  An American retrospective evaluation of vascular trauma, 
and in particular intravascular shunt use, has also recently been published 10. This 
paper described shunt usage, rates of limb salvage and mortality, shunt thrombosis, 
length of time shunts were in place, and the operation at definitive repair.  
 
The epidemiology of trauma is very different in Canada than in the United States.  
Since penetrating trauma is much less prevalent in Canada, it would stand to reason 
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that the epidemiology of traumatic vascular injuries would likewise have a different 
distribution. Moreover, vascular trauma may be more likely to be managed by a 
vascular surgeon in Canada than a trauma surgeon as compared to the United 
States, where many trauma centre have in-house trauma surgeons 24 hours a day.  
 
The aim of this study was to conduct a retrospective review of vascular trauma at 
London Health Sciences Center (LHSC), a Canadian level I trauma center, over a five-
year period. Any named vessel injury of the extremities, torso, or neck was captured, 
allowing for a description of the epidemiology of vascular trauma at this Canadian 
centre and an understanding of the present usage of damage control vascular 
surgery, specifically the use of shunts, tourniquets and aortic blockers. This 
retrospective study will provide a Canadian context through which the American 
prospective data of the PROOVIT registry can be interpreted. It will allow for an 
understanding of the present Canadian incidence of named vessel injury as well as 
our adoption of damage control techniques.  This will help guide efforts in trauma 
system management, surgical education, and research and innovation. 
 
3.2 Methods 
 
The medical records and trauma registry of London Health Sciences Centre (LHSC) 
were searched for all patients with the International Statistical Classification of 
Diseases and Related Health Problems 10th revision (ICD -10) codes for vascular 
injury.  All adult trauma patients  (18 years of age or older) with injuries to named 
arterial or venous vessels in the legs, arms and torso, and neck from 1 January 2011- 
31 December 2015 were included. Data was collected using the Research Electronic 
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Data Capture (REDCap) secure data platform. Vessel injuries in the head were not 
included because of significant difference in the treatment and outcomes of these 
types of injuries.  This five-year period was selected because it is sufficiently long to 
capture a representative sample of vascular trauma, and it is sufficiently modern to 
capture the new changes in vascular trauma practice, which may have occurred 
since the lessons learned from the conflicts in Afghanistan and Iraq.  
 
The primary outcome of this study is the description of the incidence of injury to 
named vessels in the London trauma patient population. Further descriptive data 
such as demographics, baseline co-morbidities, injury type, injury mechanism, 
injury severity on presentation, modality used to characterize and identify the 
injury, type of injury encountered, and technique of repair, whether a tourniquet, 
intravascular shunt or occlusion device was used, was also be captured. Further 
information, such as if the patient presented to a trauma centre or was transferred 
from a peripheral hospital, if the surgeon was a trauma or vascular surgeon, if a 
temporary versus definitive repair was done, type of definitive repair, length of time 
the shunt was in place if used, occurrence of shunt thrombosis, fasciotomy rate, 
occurrence of compartment syndrome limb salvage and requirement for 
amputation, and mortality during hospital stay, was also collected. This information 
was obtained from the trauma registries, initial operative report, and electronic 
medical record. 
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Continuous parameters are expressed as means with standard deviations and 
medians with interquartile ranges, as appropriate. Categorical data are expressed as 
proportions. SPSS Version 23 (IBM Inc., 2011) was used for data analysis. The 
Research Ethics Board of the University Western Ontario approved this study (REB 
# 107912). 
 
3.3 RESULTS 
From 1 January 2011 to 31 December 2015, 127 patients presented with named 
vessel injuries as a result of trauma. 89 patients were male (70.1%) and the mean 
age was 40.8 years. Blunt mechanism accounted for 61.4% of injuries and the most 
common mechanism of injury was motor vehicle crash (33.1%). The most common 
penetrating mechanism was stabbing which accounted for 18.1%. The mean Injury 
Severity Score (ISS) score was 21.8 with 63.3% of patients having an ISS of 15 or 
greater. Hypotension was present in 11.3% of patients on admission. The modality 
most commonly used to identify injury was Computed Tomography Angiogram 
(CTA) (58.3%) with operative exploration being the second most common (35.4%) 
(Table 3.1). 
 
A wide range of vascular injuries was identified, with the most common being the 
descending thoracic aorta (14.3%) (Table 3.2). Non-operative management was 
most common (28.3%) followed by open surgery (48.8%) and endovascular repair 
(12.3%).  Among those trauma vascular patients who received interventions, open 
surgery was the most common (77.9%). Endovascular techniques were commonly 
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used for aortic injuries (58.3%) (Table 3.4). Only one case used a damage control 
approach with the vast majority of practitioners opting for initial definitive repair.  
There was no temporary intravascular shunt use.  The most common repair was 
with autologous vein (16.7%) and primary repair and ligation were each used 
15.9% of the time. Fasciotomies were performed 12 times, 9 of which were 
prophylactic. 12 patients died in hospital with three dying before attempted 
vascular management. Overall mortality was 9.4%. There were 3 amputations, 4 
surgical site infections and 4 strokes (Table 3.3). 
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Table 3.1 Epidemiology of vascular trauma patients 
 
 London  PROOVIT 
Total number of patients with named vessel 
injury 
127 542 
Demographics   
Male, n (%) 89 (70.1) 382 (70.5) 
Age, mean (SD), years 40.8 (18.3) 37.7 (17.4) 
BMI, mean (SD) 26.5 (5.6)  
Transferred from outside hospital, n (%) 64 (50.4)  
Comorbidities, n (%)   
Coronary artery disease 2 (1.6)  
Diabetes mellitus 4 (3.1) 11 (2.0) 
Fully anticoagulated 1 (0.8) 2 (0.4) 
Antiplatelet use 3 (2.4) 9 (1.7) 
Bleeding disorder 1 (0.8)  
Dialysis 0 (0)  
Cirrhosis 1 (0.8)  
Injury type, n (%)   
Blunt 78 (61.4) 255 (47.0) 
Penetrating 47 (37) 198 (36.5) 
Mixed 2 (1.6) 5 (0.9) 
Mechanism, n (%)   
Motor vehicle crash 42 (33.1) 152 (28.0) 
Other or unknown 35 (27.6) 134 (24.7) 
Stabbing  23 (18.1) 39 (7.2) 
Fall  9 (7.1) 39 (7.2) 
Industrial accident  8 (6.3) 17 (3.1) 
Gunshot  5 (3.9) 129 (23.8) 
Pedestrian vs auto 2 (1.6) 30 (5.5) 
Athletic injury 3 (2.4) 2 (0.4) 
Presentation   
ISS, mean (SD) 21.8 (13.8) 20.7 (14.7) 
ISS ≥15, n (%) 81 (63.3) 174 (32.1) 
Head AIS score ≥3, n (%) 23 (18.1) 65 (12.0) 
Abdominal AIS score ≥3, n (%) 36 (28.3) 78 (14.4) 
Chest AIS score ≥3, n (%) 49 (38.2) 66 (12.2) 
Extremity AIS score ≥3, n (%) 62 (48.8) 154 (28.4) 
Admission SBP, mean (SD) 125.5 (29.3) 120 (34) 
Hypotension (SBP ≤90) on arrival, n (%) 12 (11.3) 64 (11.8) 
GCS score ≤8 in arrival, n (%) 15 (14.2) 97 (17.9) 
Admission hemoglobin, mean (SD) 126 (20.0) 12.3 (2.2) 
Admission pH, mean (SD) 7.27 (0.11) 7.26 (0.15) 
Admission lactate, mean (SD) 3.5 (2.7) 4.4 (4.2) 
Platelets, mean (SD) 214.9 (71.7) 227 (77) 
Modality used to identify/characterize injury, 
n (%) 
  
Operative exploration 45 (35.4) 161 (29.7) 
CTA 74 (58.3) 215 (39.6) 
Duplex ultrasound 0 (0) 17 (3.1) 
Traditional Angiography 5 (3.9) 62 (11.4) 
MRA 2 (1.6)  
Transesophageal echo 1 (0.8)  
Type of injury identified, n (%)   
Transected 65 (51.2) 136 (25.1) 
Occlusion 13 (10.2) 96 (17.7) 
Partial transection or flow limiting defect 45 (35.4) 138 (25.5) 
Pseudoaneurysm 11 (8.7) 49 (9.0) 
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Table 3.2 Distribution of vascular injuries 
Named Vessel injured Total injuries (n = 147) 
Neck, n(%) 30 (20.4) 
Common carotid 1 (0.7) 
Internal carotid 6 (4.1) 
External carotid 0 (0) 
Vertebral artery 17 (11.6) 
Superior thyroid artery 1 (0.7) 
Facial artery 1 (0.7) 
Internal jugular vein 2 (1.4) 
External jugular vein 2 (1.4) 
Thorax, n (%) 30 (20.4) 
Aortic arch 3 (2.0) 
Descending thoracic aorta 21 (14.3) 
Innominate artery 1 (0.7) 
Subclavian artery  1 (0.7) 
Coronary artery 1 (0.7) 
Internal mammary artery 1 (0.7) 
Intercostal artery 1 (0.7) 
Inferior vena cava 1 (0.7) 
Innominate vein 0 (0) 
Subclavian vein 0 (0) 
Abdomen/Pelvis, n (%) 29 (19.7) 
Abdominal aorta 3 (2.0) 
Common iliac 1 (0.7) 
External iliac 2 (1.4) 
Internal iliac 1 (0.7) 
Celiac Artery 1 (0.7) 
Common hepatic artery 0 (0) 
Superior mesenteric artery 0 (0) 
Renal artery 3 (2.0) 
Splenic artery 0 (0) 
Left gastric artery  1 (0.7) 
Middle colic artery 1 (0.7) 
Internal pudendal artery 4 (2.7) 
Superior gluteal artery 2 (1.4) 
Inferior gluteal artery 1 (0.7) 
Obterator artery 2 (1.4) 
Lateral femoral circumflex artery 1 (0.7) 
Retro Hepatic IVC 0 (0) 
Infra-renal IVC 3 (2.0) 
Iliac vein 0 (0) 
Portal vein 0 (0) 
Renal vein 2 (1.4) 
Splenic vein 0 (0) 
Gonadal vein  2 (1.4) 
Upper extremity, n (%) 36 (24.5) 
Axillary artery 3 (2.0) 
Brachial artery 13 (8.8) 
Radial artery 7 (4.8) 
Ulnar artery 7 (4.8) 
Posterior circumflex humeral artery 1 (0.7) 
Princeps pollicis 1 (0.7) 
Axillary vein 0 (0) 
Basilic vein 2 (1.4) 
Brachial vein 2 (1.4) 
Lower extremity, n (%) 22 (15.0) 
Common femoral artery 0 (0) 
Superficial femoral artery 3 (2.0) 
Deep femoral artery 0 (0) 
Popliteal artery 7 (4.8) 
Anterior tibial artery 4 (2.7) 
Posterior tibial artery 3 (2.0) 
Peroneal artery 0 (0) 
Common femoral vein 0 (0) 
Superficial femoral vein 2 (1.4) 
Deep femoral vein 0 (0) 
Popliteal vein 2 (1.4) 
Great saphenous vein 0 (0) 
Posterior tibial vein 1 (0.7) 
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3.3 Management and complications of vascular injuries 
Management  n(%) London PROOVIT 
Non-operative management 39 (28.3) 276 (50.9) 
Endovascular repair 17 (12.3) 40 (7.4) 
Initial non-definitive open surgery 1 (0.7) 165 (37.8) 
Definitive open surgery 59 (42.8) 126 (23.2) 
Damage control technique 1 (0.7) 57 (10.5) 
Fasciotomy 12 (8.7)  
Shunt used 0 (0) 14 (2.6) 
Ligation 22 (15.9) 31 (5.7) 
Primary repair 22 (15.9) 37 (6.8) 
Autologous repair 23 (16.7) 61 (11.3) 
Synthetic graft 3 (2.2) 7 (1.3) 
Died before vascular management 3 (2.2)  
Embolization 9 (6.5)  
Complications    
In hospital mortality 12 (9.4) 48/376 (12.7) 
Amputation 3 (2.4) 18 (3.3) 
Compartment syndrome 3 (2.4)  
Shunt thrombosis 0 16 (3.0) 
Dislodged shunt 0  
Surgical site infection 4 (3.1) 6 (1.1) 
Stroke 4 (3.1) 12 (2.2) 
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3.4 Management of specific arterial injuries 
 Nonoperative 
management 
Endovascular 
repair 
Open Surgery Died before 
repair 
Neck, n (%)     
Common carotid 1/1 (100) 0/1 0/1 0/1 
Internal carotid 6/6 (100) 0/1 0/1 0/1 
External carotid 0 0 0 0 
Vertebral artery 17/17 (100) 0/17 0/17 0/17 
Thorax, n (%)     
Aortic arch 1/3 (33.3) 1/3 (33.3) 1/3 (33.3) 0/1 
Descending thoracic aorta 7/21 (33.3) 13/21 (61.9) 1/21 (4.8) 0/1 
Innominate artery 1/1 (100) 0/1 0/1 0/1 
Subclavian artery  0/1 1/1 (100) 0/1 0/1 
Abdominal/Pelvis, n (%)     
Abdominal aorta 2/3 (66.6) 0 1/3 (33.3) 0/1 
Common, external, or 
internal iliac arteries 
0/4 0/4 1/4 (25) 3/4 (75) 
Celiac artery 1/1 (100) 0/1 0/1 0/1 
Renal artery 2/3 (66.6) 0/3 1/3 (33.3) 0/3 
Upper extremity, n (%)     
Axillary artery 1/3 (33.3) 1/3 (33.3) 1/3 (33.3) 0/3 
Brachial artery 0/13 0/13 13/13 (100) 0/13 
Radial artery 0/7 0/7 7/7 (100) 0/7 
Ulnar artery 0/7 0/7 7/7 (100) 0/7 
Lower extremity, n (%)     
Common, superficial or 
deep femoral artery 
0/3 2/3 (66.6) 1/3 (33.3) 0/3 
Popliteal artery 0/7 0/7 7/7 (100) 0/7 
Anterior tibial artery 1/4 (25) 0/4 3/4 (75) 0/4 
Posterior tibial artery 0/3 0/3 3/3 (100) 0/3 
Peroneal artery 0 0 0 0 
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There were 49 peripheral arterial injuries. Prehospital tourniquets were used on 6 
occasions (12.2%) with only one having a tourniquet time recorded (4.5 hours). 
Tourniquets were applied in the trauma bay 4 times.  Resuscitative thoracotomies 
were performed three times, on two occasions by a general surgeon and once by a 
trauma surgeon. No REBOA was used (Table 3.5). 
 
Vascular surgeons managed the majority of the vascular injuries (n = 77), with 
plastic surgeons (n = 11), interventional radiologists (n = 11), and general surgeons 
being the next most common (n = 9) (Table 3.6).  All vascular injuries managed by 
plastic surgery were in the upper extremity. Interventional radiology deployed 
endovascular stents to the subclavian artery and the axillary artery.  All other 
interventional radiology interventions were embolizations to the internal pudendal, 
superior and inferior gluteal, obturator, and posterior circumflex of the humeral 
arteries. Neurology managed two vertebral artery injuries. 
 
3.5 Tourniquets, fasciotomies, and resuscitative techniques (n) 
 London n (%) PROOVIT n (%) 
Peripheral artery injuries 49 233 
Prehospital tourniquet use 6/49 (12.2) 47/233 (20.2) 
Trauma bay tourniquet use 4/49 (8.2)  
Fasciotomy, prophylactic 9/49(18.4) 33/233 (14.2) 
Fasciotomy therapeutic 3/49 (6.1) 19/233 (8.2) 
REBOA use 0  
Resuscitative thoracotomy 3   
Temporary intravascular shunt use 0  
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3.6 Discipline of physician who managed the vascular injury 
Discipline managed vascular injury Total patients (n=127) 
General surgeon 9 
Trauma surgeon 3 
Vascular surgeon 77 
Orthopedic surgeon 2 
Thoracic surgery 3 
Cardiac surgery 2 
Plastic surgery 11 
Otolaryngology 3 
Urology 1 
Gynecology 1 
Neurosurgery 2 
Interventional radiology 11 
Neurology 2 
 
3.4 DISCUSSION 
In order to improve linkage of management of vascular traumatic injuries to short 
and long-term outcomes, the American Prospective Observational Vascular Injury 
Treatment (PROOVIT) registry was initiated 9. This registry was inspired by the 
success of military vascular trauma registries in Iraq and Afghanistan 5-7. Their view 
was to document the evolution of vascular care from the prehospital environment to 
definitive management.  Concepts such as tourniquet use, temporary intravascular 
shunts and damage control principles have been used extensively in the military 
setting with good success and are now being incorporated into civilian institutions 
practice 1,2,11,12. 
 
The PROOVIT registry may be very important in monitoring the effectiveness of 
these damage control techniques as well as the expanding field of endovascular 
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intervention for trauma. This registry captures patients from 13 American level I 
Trauma Centres and one level II trauma Centre. However, the type of trauma 
experienced, as well as the resources available, and training of the practitioners 
providing the care and therapy may be different than what exists in Canada. While 
establishing a Canadian prospective vascular trauma database is an ambitious way 
to examine the Canadian experience, a faster and less costly approach is to 
retrospectively examine Canadian vascular trauma and use that data as a lens 
through which the American experience can be interpreted.  By knowing the ways in 
which the Canadian and American vascular trauma population are similar, and the 
ways that they differ, the findings from the PROOVIT registry that are applicable to 
Canadian practice can be identified.  
 
The Canadian patients were of similar age (40.8 vs. 37.7) (hereafter, LHSC results 
are given before those from PROOVIT) and were also predominantly male (70.1% 
vs. 70.5%).  The mean injury severity score between the two groups was similar (ISS 
21.8 vs. ISS 20.7) with this study having a larger proportion of patients with ISS 
scores above 15 (63.3% vs. 32.1%). Both groups had very similar rates of 
hypotension on admission (11.3% vs. 11.8%). Canadian patients were more likely to 
have suffered from a blunt mechanism of injury (61.4% vs. 47%). The most common 
mechanism of blunt injury was motor vehicle crash for both populations (33.1% vs. 
28.0%); however, whereas the most common penetrating mechanism in the 
PROOVIT registry was gunshot (23.8%) at LHSC the most common penetrating 
mechanism was stabbing (18.1%).  
  
42 
 
The most common non-operative method of identifying vascular injury was CTA but 
this modality was more common in the Canadian experience (58.3% vs. 39.6%) with 
the PROOVIT patients receiving duplex ultrasound (0% vs. 3.1%) and traditional 
angiography more often (3.9% vs. 11.4%).  The Canadian patients were more likely 
to receive operative exploration (35.4% vs. 29.7%).  The most common vessel 
injuries in this study was the descending thoracic aorta (14.3%) followed by the 
vertebral artery (11.6%) whereas the most commonly injured vessel in the 
PROOVIT registry was the internal carotid artery (11.4%). This difference may be 
reflective of the greater proportion of blunt trauma in the Canadian trauma 
population. 
 
Both studies found non-operative intervention was the most common but it was 
more frequent in the PROOVIT registry (28.3% vs. 50.9%).  Endovascular 
intervention was more popular in Canada (12.3% vs. 7.4%). This difference may be 
due to the prevalence of blunt aortic injury in the Canadian group.  
 
No patient received a temporary intravascular shunt in this study whereas 2.6% did 
in PROOVIT. This study found that 12.2% of extremity arterial injuries received 
prehospital tourniquets whereas 20.2% did in the PROOVIT registry.  Unfortunately 
the time of tourniquet application was poorly documented with only one tourniquet 
time available and that being a long application of 4.5 hours. In PROOVIT 25% 
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lacked documentation of tourniquet time and 40.4% of tourniquets were on for less 
than one hour. 
 
The Canadian vascular trauma population is sufficiently similar to the population of 
the PROOVIT registry for the results that are accrued from the PROOVIT registry to 
be of great interest.  In particular endovascular techniques for trauma are being 
expanded to junctional areas such as subclavian or axillary arteries13 as well as 
more peripheral arteries 14. There were Canadian trauma patients receiving these 
therapies, and knowing the outcomes of these interventions will be very important. 
That outcomes information can be obtained from the PROOVIT registry and will 
likely be applicable to the Canadian trauma population. 
 
One way in which the Canadian and American populations likely differ is in who 
repairs the vascular injury.  In our study, vascular surgeons repair the majority of 
vascular trauma, with only three injuries in five years being repaired by a trauma 
fellowship trained surgeon.  Multiple subspecialty surgeons were involved in 
managing vascular injuries.  This diffusion of who is responsible for vascular trauma 
is likely very different from an American centre who may have an in-house trauma 
surgeon managing the majority of vascular injuries.  This is an important Canadian 
characteristic to recognize and appreciate as findings and outcomes of vascular 
trauma research are attempted to be disseminated and Canadian trauma systems 
evolve and implement new techniques. 
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Tourniquet use is much less frequent in Canada.  Not all peripheral arteries need a 
tourniquet. A distal radial transection will likely go into spasm and can safely be 
controlled with direct pressure.  However, military experience has shown that 
tourniquet use can be safe and effective11,16. If a tourniquet is being used, 
documenting when it is applied and removed is important both for an 
understanding of the patient’s recovery and ischemic injury, but also to be able to 
study the effect of this tool in a civilian environment.  Military patients are usually 
air-lifted quickly to a surgical facility meaning that tourniquets are on for only a 
short time15.  If civilian application times are consistently longer then the algorithm 
for their use will likely differ from our military counterparts. 
 
Commercial intravascular temporary shunts are available at LHSC and could have 
been used during the study period. There have been civilian studies showing their 
safe and effective use for both damage control and staged orthopedic vascular 
injuries 10. The PROOVIT registry will collect further data with respect to the safety 
and optimal use of this tool. This may prove to be an example of a vascular trauma 
tool worthy of adoption into the Canadian armamentarium.  
 
The vascular trauma patient in this study had similar age and injury severity to 
those in the PROOVIT registry; however, was more likely to have suffered a blunt 
injury and was likely treated by a vascular surgeon. No temporary intravascular 
shunts were used and prehospital tourniquet use was less frequent and, when 
applied, their time of occlusion was poorly captured.  The PROOVIT registry may be 
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of particular use to Canadian patients in tracking the outcomes of endovascular 
trauma interventions as endovascular therapies were used for aortic injuries, 
junctional injuries and extremity vascular injuries at this Canadian trauma center. 
Hopefully with the present data the PROOVIT experience can be optimally 
interpreted and lessons learned applied to a Canadian context. 
  
  
46 
3.5 REFERENCES 
1. Rasmussen TE, Dubose JJ, Asensio JA, et al. Tourniquets, vascular shunts, and 
endovascular technologies: esoteric or essential? A report from the 2011 
AAST Military Liaison Panel. The journal of trauma and acute care surgery. 
2012;73(1):282-285. 
2. Fox N, Rajani RR, Bokhari F, et al. Evaluation and management of penetrating 
lower extremity arterial trauma: an Eastern Association for the Surgery of 
Trauma practice management guideline. The journal of trauma and acute care 
surgery. 2012;73(5 Suppl 4):S315-320. 
3. Passos E, Dingley B, Smith A, et al. Tourniquet use for peripheral vascular 
injuries in the civilian setting. Injury. 2014;45(3):573-577. 
4. Pereira BM, Chiara O, Ramponi F, et al. WSES position paper on vascular 
emergency surgery. World journal of emergency surgery : WJES. 2015;10:49. 
5. Markov NP, DuBose JJ, Scott D, et al. Anatomic distribution and mortality of 
arterial injury in the wars in Afghanistan and Iraq with comparison to a 
civilian benchmark. Journal of vascular surgery. 2012;56(3):728-736. 
6. Clouse WD, Rasmussen TE, Peck MA, et al. In-theater management of 
vascular injury: 2 years of the Balad Vascular Registry. Journal of the 
American College of Surgeons. 2007;204(4):625-632. 
7. Gifford SM, Aidinian G, Clouse WD, et al. Effect of temporary shunting on 
extremity vascular injury: an outcome analysis from the Global War on 
Terror vascular injury initiative. Journal of vascular surgery. 2009;50(3):549-
555; discussion 555-546. 
  
47 
8. Belenkiy SM, Batchinsky AI, Rasmussen TE, Cancio LC. Resuscitative 
endovascular balloon occlusion of the aorta for hemorrhage control: Past, 
present, and future. The journal of trauma and acute care surgery. 2015;79(4 
Suppl 2):S236-242. 
9. DuBose JJ, Savage SA, Fabian TC, et al. The American Association for the 
Surgery of Trauma PROspective Observational Vascular Injury Treatment 
(PROOVIT) registry: multicenter data on modern vascular injury diagnosis, 
management, and outcomes. The journal of trauma and acute care surgery. 
2015;78(2):215-222; discussion 222-213. 
10. Inaba K, Aksoy H, Seamon MJ, et al. Multicenter evaluation of temporary 
intravascular shunt use in vascular trauma. The journal of trauma and acute 
care surgery. 2016;80(3):359-365. 
11. Kragh JF, Jr., Littrel ML, Jones JA, et al. Battle casualty survival with 
emergency tourniquet use to stop limb bleeding. The Journal of emergency 
medicine. 2011;41(6):590-597. 
12. Ball CG, Feliciano DV. Damage control techniques for common and external 
iliac artery injuries: have temporary intravascular shunts replaced the need 
for ligation? The Journal of trauma. 2010;68(5):1117-1120. 
13. DuBose JJ, Rajani R, Gilani R, et al. Endovascular management of axillo-
subclavian arterial injury: a review of published experience. Injury. 
2012;43(11):1785-1792. 
14. Desai SS, DuBose JJ, Parham CS, et al. Outcomes after endovascular repair of 
arterial trauma. Journal of vascular surgery. 2014;60(5):1309-1314. 
  
48 
15. Beckett A, Pelletier P, Mamczak C, Benfield R, Elster E. Multidisciplinary 
trauma team care in Kandahar, Afghanistan: current injury patterns and care 
practices. Injury. 2012;43(12):2072-2077. 
16. Subramanian A, Vercruysse G, Dente C, Wyrzykowski A, King E, Feliciano DV. 
A decade's experience with temporary intravascular shunts at a civilian level 
I trauma center. J Trauma. 2008 Aug; 65 (2): 316-24. 
  
  
49 
 
 
 
 
 
 
 
CHAPTER 4 
 
NOVEL JUNCTIONAL VASCULAR INJURY OCCLUSION DEVICE   
  
50 
CHAPTER 4:  NOVEL JUNCTIONAL VASCULAR INJURY OCCLUSION DEVICE 
 
4.1 Introduction 
Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an emerging 
technique used to support blood pressure and decrease hemorrhage in trauma. As it 
continues to be studied and experience increases, new applications of this 
technology are being proposed. The most enthusiastic supporters have suggested 
REBOA as a potential pre-hospital intervention to enable the exsanguinating trauma 
patient to survive until surgical intervention1.  Given the injury pattern of modern 
combat casualties, ultrasound-guided placement of a REBOA device in the distal 
aorta may help more patients survive evacuation to surgical management. In order 
for this to be feasible, a novel device needs to be developed that is not encumbered 
by a long wire, is easy to use, and can manage damaged iliac and femoral vessels. 
 
Modern conflicts have seen a shift in the type of weapons used against coalition 
soldiers.  In the recent Afghan war, fewer soldiers were injured with rifles and 
conventional ballistic weapons than were injured by improvised explosive devices 
(IED)2,3. Medically, it is most appropriate to classify these weapons by their target: 
crowd attack IED (CA-IED), anti-vehicle IED (AV-IED), and the antipersonnel IED 
(AP-IED)4. CA-IEDs cause injury by projectile fragments and their effect may be 
magnified by enclosed spaces, AV-IED have very large explosions and cause injuries 
similar to high-energy motor vehicle collisions, and AP-IEDs cause multiple 
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amputations and significant pelvic and perineal injury4,5.  These victims can present 
the challenge of non-compressible torso hemorrhage6,7. 
 
Combat pre-hospital medical care has simultaneously made great advancements.  
With Tactical Combat Casualty Care (TCCC) and personal protective equipment 
(PPE), more soldiers are being treated for, and surviving, potentially preventable 
causes of death on the battlefield 8. However, there is very little a forward military 
physician can offer a patient with non-compressible torso hemorrhage other than 
rapid evacuation to a surgical facility. Could REBOA temporize the bleeding IED 
victim for transportation to the operating room? If the correct device was available 
pre-hospital combat use of the REBOA could save soldiers lives. 
 
4.1.1 Standard REBOA technique 
In 2011, Stannard et al. described the modern five-step technique of REBOA 
insertion via femoral artery cannulation and defined three zones of balloon 
deployment. The five steps for the REBOA procedure are: 1) arterial access and 
sheath insertion, 2) balloon positioning, 3) balloon inflation, 4) balloon deflation, 
and 5) sheath removal.  They defined Zone I as the thoracic aorta extending from the 
subclavian artery to the celiac artery, Zone II as the non-occlusion zone between the 
celiac artery and renal arteries and Zone III as the infrarenal aorta to the iliac 
bifurcation (Figure 4.1).  Deployment of REBOA in zone I is analogous to the 
hemostatic control of a resuscitative thoracotomy with cross clamping of the 
thoracic aorta, which controls hemorrhage from the abdomen and pelvis and 
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increases cerebral and coronary blood flow. REBOA in Zone III provides occlusion to 
help control pelvic or junctional hemorrhage without causing visceral ischemia 9. 
Figure 4.1 Zones of REBOA deployment 
 
 
 Aortic zones related to REBOA. Zone I extends from the origin of the left 
subclavian artery to the celiac artery and is a potential zone of occlusion. Zone II 
extends from the celiac artery to the lowest renal artery and is a a no-occlusion  
zone. Zone III exists from the lowest renal artery to the aortic bifurcation. REBOA in  
this zone may provide particular utility for instances of pelvic and junctional  
femoral hemorrhage.  
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4.1.2 REBOA in the Military 
The origins of REBOA are in military medicine.   Lieutenant-Colonel Carl Hughes of 
the United States Army Medical Corps, used balloon aortic occlusion in two patients 
in the Korean Conflict and although both died he speculated that this technique 
could save lives in the future 10.  Although originating in the treatment of combat 
casualties, aortic balloon occlusion for hemorrhage control was first adopted in the 
civilian context for the management of abdominal aortic aneurysms, 11 and it is only 
in the past decade that REBOA for trauma patients has transitioned from an 
experimental technique to a tool for clinical study and use 12. 
 
Interest in REBOA re-emerged within the military context during the Afghanistan 
and Iraq conflicts and military surgeons have been actively involved in its research 
and development 12. The American military has published the Joint Trauma System 
Clinical Practice Guideline for REBOA, identifying its use as an alternative approach 
to thoracotomy in some cases, and described a role for preemptive placement in 
high-risk unstable patients 13. This guideline is designed to apply in a location with 
surgical capability. A REBOA data tool is used to capture the technique’s use for 
study. A retrospective analysis indicated that as many as 18% of modern combat 
casualties could benefit from REBOA treatment 14. This technique is less morbid 
than a resuscitative thoracotomy and may have a role in the hypotensive pre-arrest 
patient by increasing their blood pressure and decreasing hemorrhage before 
progression to arrest and the need for resuscitative thoracotomy15.  A recent 
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systematic review showed that REBOA increased systolic blood pressure by a mean 
of 53 mmHg (95% confidence interval 41-61 mmHg), but it did not demonstrate a 
clear reduction in hemorrhage-related mortality 16.  The studies comprising this 
review were case series, case reports and cohort studies; as registries accrue, 
prospective studies may illuminate additional circumstances showing an advantage 
of the REBOA technique in treating trauma patients with difficult to control 
hemorrhage.  
 
Where REBOA portends great theoretical advantage is in facilitating the evacuation 
of combat casualties from the field to definitive surgical management. Morrison et 
al.’s analysis of the UK joint trauma registry over a ten-year period identified 174 
deaths that met indications for REBOA. One hundred forty-five of these patients died 
before reaching hospital (83%), with a mean time to death of 75 minutes. The 
authors suggested that REBOA could act as en route hemorrhage control to get these 
casualties to a surgeon14.  This application requires that REBOA be used in a pre-
surgical environment. Before REBOA can be implemented in battlefield operations 
in a forward environment, medical leadership must make decisions regarding what 
method should be used to gain arterial access, which patients this therapy would 
apply to, the zone of REBOA deployment, and what training would be required for 
medical officers using this therapy.  
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4.1.3 Arterial Access 
Arterial access is the first step in deployment of REBOA and providers currently 
have the option of a formal vascular cut-down, external anatomical landmarking 
with percutaneous access, or ultrasound-guided percutaneous access 9. Vascular 
cut-down yields direct visualization of the target vessel, facilitating reliable 
cannulation of the common femoral artery (CFA) in a pulseless or profoundly 
hypotensive patient; however, it can be time consuming and requires surgical 
training. Landmark percutaneous access carries increased risk of venous 
cannulation, increased risk of vascular injury, and overall lower success rates 17. 
Additionally, the probability of successful placement is compromised in the 
extremely hypotensive or pulseless patient 16. Ultrasound-guided femoral artery 
access has the advantage of making catheter placement possible in the patient with 
severe hypotension without requiring a cut-down.  It may increase the speed of 
percutaneous access, and the ultrasound can also be used to confirm the positioning 
of the balloon once it is deployed 1. In the civilian context, all three techniques are 
used, with 50% gaining access by cut down, 28% by land marks and 11% by 
ultrasound guidance18.  For the combat casualty in a non-surgical environment, 
ultrasound-guided percutaneous vascular access is the most attractive option; it 
alleviates the training requirement for performing a cut-down, may still be 
performed in the context of extreme hypotension, and ultrasound use is a skill 
already familiar to most military physicians. An environment that could facilitate 
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forward REBOA placement could be equipped with portable ultrasound, making this 
approach both feasible and efficacious. 
 
4.1.4 REBOA and evacuation 
Exsanguination is the number one cause of death on the battlefield and thus 
hemorrhage control must be the top priority of the provider treating the injured 
soldier 19,20. REBOA has the potential to help combat casualties survive to surgery in 
situations where they would otherwise die without aortic occlusion 14; however, 
delaying transport of a combat casualty while attempting to perform interventions 
could also be problematic and deadly.  In the hands of experts, REBOA can be 
deployed in six minutes18,21. We believe this represents a reasonable benchmark by 
which military REBOA programs should self-evaluate. If a combat REBOA program 
were implemented, a potential algorithm could be as follows: if an IED victim has 
hypotension after tourniquet application, pelvic binder application, and fluid 
resuscitation; and, if evacuation to the operating room will be greater than 20 
minutes, then REBOA should be considered (Figure 4.2).  Rapid evacuation to a 
surgical facility should not be delayed for REBOA insertion. Given that the mean 
time to death of patients that would have potentially benefited from REBOA was 75 
minutes 14, a patient who could be imminently evacuated would likely derive greater 
benefit from rapid access to higher-level surgical care than from delayed evacuation 
and REBOA placement. 
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Figure 4.2 Potential algorithm for forward medical center REBOA use 
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4.1.5 Zone of deployment 
The most common REBOA zone of deployment in the civilian setting is Zone 1 
(78.6%)18.  Deployment in the thoracic aorta will control all hemorrhage below the 
level of the diaphragm, much like an aortic cross-clamp in a resuscitative 
thoracotomy. The major disadvantage of deployment at this zone is the associated 
spinal cord and intestinal ischemia15,22.  In the swine model, 30 minutes of occlusion 
is well tolerated but by 90 minutes there is evidence of liver necrosis and renal 
dysfunction 23. Zone 3 deployment does not offer control of intra-abdominal 
hemorrhage; however, it provides excellent control of pelvic and junctional bleeding 
without the risk of visceral ischemia9,15. Zone 3 poses fewer technical challenges for 
placement, can use shorter wires than with Zone I deployment, and may be an easier 
skill to teach and maintain for non-surgeon medical officers. Zone 3 REBOA will 
likely be less cumbersome in a more forward environment, and it does not run the 
risk of life-threatening visceral ischemia in the context of delayed evacuation. While 
personal protective equipment provides some thoraco-abdominal protection, the 
injury pattern of the AP-IED is associated with significant pelvic injury that may be 
amenable to this technique5. These characteristics make anatomical Zone 3 
deployment the most practical location for the pre-hospital combat physician. 
 
4.1.6 Training  
REBOA is a new technique to military medicine, with the majority of data on REBOA 
coming from trauma and vascular surgeons with considerable endovascular 
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experience, working in a civilian setting 18. Many of the pioneers of this technique 
espouse caution with its rapid adoption 24. Japan has one of the largest experiences 
with REBOA in civilian trauma. In their system, emergency physicians can be 
credentialed after performing REBOA three times during residency training 25. 
REBOA patients may have their device placed by an emergentologist, and definitive 
treatment provided by interventional radiology without direct surgeon involvement 
26. Prospective data from the Japan Trauma Data Bank was used to match REBOA 
patients to propensity score-adjusted non-REBOA patients, demonstrating a 
decrease in survival in the REBOA patients by an odds ratio of 0.30 (95% confidence 
interval, 0.23-0.4) 25. A 24 patient Japanese series demonstrated that REBOA did 
increase mean systolic blood pressure, but they encountered complications such as 
the balloons not deflating, vascular injury while trying to obtain access, and a 12.5 % 
requirement for amputation, one of which arose from an iatrogenic vascular injury 
27. The American experience as captured in the Aortic Occlusion for Resuscitation in 
Trauma and Acute Care Surgery (AORTA) registry has only reported three 
endovascular specific complications, including distal embolism and pseudo-
aneurysm; no patients required amputations in the 46 REBOA patients captured by 
the registry 18. Early American clinical series did not demonstrate any procedure-
related deaths or major complications 21.  Some authors have cautioned against the 
widespread adoption of REBOA, fearing that use by less qualified practitioners may 
generate poorer outcomes before this technique has been adequately studied and its 
indications for use and required provider training have been defined 24.  Most 
contributors to the American REBOA registries are trauma and vascular surgeons 
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who have taken, or are instructors on, REBOA training courses 18,28,29. It is important 
that medical officers placing REBOA in combat environments be adequately trained 
and their skillset maintained. 
 
A pre-hospital military physician may be a trained surgeon, but more likely will be a 
general duty medical officer with experience in central line placement and 
ultrasound use, but not in endovascular techniques.  Training curricula would need 
to be developed with cadaveric and animal models to ensure that these forward 
physicians could safely place the device and know which patients may potentially 
benefit from the intervention.  As mentioned above, an ultrasound-guided 
percutaneous technique would likely be the most appropriate.  With the 
development of smaller caliber devices (7 Fr)12, the possibility of training a medical 
officer to safely insert a Zone III REBOA to facilitate transportation of an IED 
casualty to a surgical facility is likely an achievable future reality, but we must move 
towards this goal with prudence and careful planning supported by robust research. 
A strong training curriculum focused on both skillset acquisition and maintenance is 
crucial to a successful combat REBOA program. 
 
4.1.7 Future of combat REBOA 
Both military and civilian trauma surgical centers are using REBOA for the 
treatment of hemorrhaging trauma patients 13,30.  Responsibly, these therapies are 
being utilized within a framework of active clinical registries and ongoing research 
to clarify the use, safety, and indications of this new technique. REBOA as it is 
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presently designed is not yet ready for the pre-hospital or combat pre-surgical 
environments and should only be used in well-trained hands in an environment 
with ready surgical capabilities. However, REBOA does have promise as a forward 
medical tool if a new device could be designed to meet the needs of this very 
different medical environment. Lives would be saved if a physician at a forward 
medical center, with appropriate training and skill set maintenance, was able to 
insert a balloon under ultrasound-guidance to occlude the distal aorta of an unstable 
casualty to allow them to survive to surgery where they otherwise would have died. 
Recent experience in Iraq and Afghanistan demonstrated a 98% survival rate for 
those injured soldiers that could be evacuated to a facility with surgical capability 31.  
For this reason it is important to develop tools that have the potential to increase 
the proportion of battlefield injured that make it to surgical care.  If an appropriate 
internal tourniquet were designed it would likely be able to save soldiers’ lives, 
enabling evacuation to a surgeon’s life-saving care. 
 
4.1.8 Requirements for a combat REBOA device 
 The REBOA equipment presently available requires insertion wires that are over a 
meter long and it needs a large sterile area to control and insert this equipment 9. 
That setup is not conducive to a forward combat medical environment. Once 
inserted the presently cumbersome setup would not be easily transported in a 
medevac helicopter or armored ambulance. Also the person inserting this device 
will likely be a physician but not necessarily a surgeon. With the current REBOA 
implementations the guide wire must be manipulated up to the aortic zone of 
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deployment.  If the iliacs have been damaged by an IED blast this could become a 
difficult or impossible task. Another pitfall would be if the wire advanced down the 
contralateral iliac rather than up the aorta.  Inflating a fluid filled balloon in the iliac 
or femoral arteries could be a devastating complication. For a combat occlusion 
device to be feasible it would have to: be easy to use, have a short wire, be able to be 
transported with the patient, be able to manage blast injured pelvic vessels, be able 
to tolerate contralateral iliac intubation. We have designed a novel device to meet 
these requirements. 
 
4.2 CREATION OF OCCLUSION DEVICE 
4.2.1 Methods 
A novel device was designed to cause Zone 3 aortic occlusion (Figure 4.3). Rather 
than using a Seldinger technique, guiding the apparatus over a wire, a latex balloon 
expands up the vessel as it inflates.  The device is self-guided. This 16 mm x 22 cm 
balloon inflates up the vessel. As the balloon expands it carries a wire that is 
attached inside the balloon with it. This allows for a measurement of length of 
deployment as well as the application of gentle pressure to facilitate deployment. 
The balloon is inflated from a pressurized carbon dioxide (CO2) canister. 
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Figure 4.3 Novel iliac and aortic occlusion device 
 
 
Device construction 
A 16 g CO2 canister was used to inflate the balloon. This was attached with a 
variable valve allowing for control of inflation and a pressure gauge to monitor 
balloon internal pressure (Figure 4.4). A ¼ inch ball valve was used as a pressure 
release to allow for deflation of the balloon and retraction of the device (Figure 4.5).  
A 1.1 mm diameter braided wire enters the device through a rubber seal of near 
identical diameter. When the balloon device is deployed a plastic bead is pulled into 
the rubber seal.  The more inflated the balloon becomes, the greater of the force of 
the bead into the seal preventing air leak. The balloon is 22 cm in length and 1.6 cm 
in diameter. It begins invaginated in the device and then inflates and deploys 
  
64 
longitudinally with CO2 inflation (Figure 4.4). Once maximum length is achieved the 
balloon will further distend laterally.  
 
The balloons were fabricated by rolling sheets of 0.05 mm latex onto a dowel and 
applying liquid latex along the seam (Figure 4.5). The cylindrical latex tube was then 
rolled off the dowel (Figure 4.6) and then attached with epoxy to the braided wire 
(Figure 4.7) and invaginated into the device. 
 
Figure 4.4 CO2 inflation devices 
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Figure 4.5 Rolling of the latex on the dowel 
 
 
 
 
Figure 4.6 Rolling the balloon off of the dowel 
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Figure 4.7 Balloon attached to the braided wire 
 
 
 
 
Occlusion pressure testing  
In order to determine against what pressure the device could obtain and maintain 
occlusion, a testing model was created (Figure 4.8).  This aortic model consisted of a 
2 cm diameter vinyl model aorta with 2 cm diameter vinyl iliac limbs that had water 
pumped through it at variable pressures (Figure 9).  A PSI gauge was placed in 
continuity with the water flow to measure how high the water pressure could be 
raised maintaining balloon occlusion before rupture.  During each experiment the 
testing apparatus and the PSI gauge were video taped so that an accurate PSI 
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rupture pressure could be recorded and occlusion of flow was confirmed (Figure 
4.10). A variable speed pump was used to increase the water pressure until rupture 
was obtained and PSI recorded.  
 
Figure 4.8 Aortic occlusion testing apparatus 
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Figure 4.9 Un-occluded flow through testing apparatus 
 
 
Figure 4.10 PSI gauge and camera mount 
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In order to determine the internal balloon pressure that would cause rupture, a 
pressure gauge was put in series with the device and the balloon was gradually 
inflated until the balloon ruptured.  The gauge was video taped during the 
experiments to ensure accurate pressure recording.  
 
4.2.2  Results 
The invaginated balloon of the device would expand out of the tip of the catheter 
until it reached its full length (Figure 4.11) and then would further stretch to up to 
5.5 cm in diameter (Figure 4.12).  
 
Figure 4.11 Deployed balloon 
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Figure 4.12 Further inflation of deployed balloon
 
The device was deployed into the occlusion pressure testing apparatus (Figure 
4.13).  Once occlusion had been obtained the upstream water pressure was 
gradually increased until the balloon ruptured.  The mean rupture pressure was 561 
mmHg (SD 124) with the minimum rupture pressure of 362 mmHg, well above any 
physiologic human blood pressure (Figure 4.14). The balloon internal pressures 
were also measured and as one would expect were equal to upstream pressures at 
the time of rupture. 
 
Once the device had been shown to be able to deploy and occlude flow above 
physiologic pressures, the deployment apparatus was miniaturized. The final 
deployment catheter had an external diameter of 6.35 mm and an internal diameter 
of 2.76 mm (Figure 4.15). This device could be deployed in a human sized model 
with a 2 cm aorta and 1 cm iliac vessels (Figure 4.16). 
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Figure 4.13 Balloon occluding pressure-testing apparatus 
 
Figure 4.14 Balloon rupture pressures 
 
The graph displays the rupture pressures for 10 balloons. The error bars represent 
standard error measurement.  
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Figure 4.15 Smaller deployment device 
 
The smaller device was then tested on aortic models of human anatomical scale with 
2 cm diameter aortic tubing and 1 cm diameter iliac tubing. The device was 
successful in occluding flow in this model. 
 
Figure 4.16 Deployment of the balloon in a human sized aortic model 
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4.2.3 Discussion 
We have created a device that can be inflated in a human scaled model and cause 
occlusion of fluid flow to above human physiologic pressures. It is easy to use 
requiring only arterial access and turning on the CO2. The device self inflated and 
self guided up the model aorta to cause effective occlusion. The internal wire allows 
the measurement of the length of deployment as well as extraction of the device. 
The next step was to test the device’s ability to occlude flow in animal tissue and in 
damaged iliac models. 
 
4.3 PORCINE MODEL TESTING 
4.3.1 Methods 
Occlusion of cadaveric porcine aorta 
A cadaveric porcine aorta was placed into the testing apparatus, replacing the 
artificial tubing. Small arterial branching vessels were suture ligated. The device 
was then used to cause flow occlusion and this was video taped. Normal saline was 
infused through the testing apparatus during cadaveric porcine experiments. The 
porcine aortas were obtained from a local abattoir on the day of slaughter.  The 
experiments were conducted on the day of slaughter (Figure 4.18). 
 
Modeling damaged iliac vessels 
In order to model the balloon progression and occlusion of flow that would occur in 
a damaged iliac, a 1 cm diameter defect was cut in the iliac vessel of the porcine 
model.  The device was then used to inflate up the damaged limb while the 
  
74 
experiment was video taped. This was done on three different porcine aortas. Three 
different balloons were used on each model for a total of nine balloons being tested 
(Figure 4.18) 
 
Figure 4.17 Porcine aorta model 
 
Figure 4.18 Porcine aorta with 1 cm diameter iliac defect with device deployed 
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4.3.2 Results 
The porcine aorta was attached to the perfusion apparatus. The device was 
deployed up the porcine iliac and aorta and occluded fluid flow. The balloon device 
was successful in occluding flow of water in a porcine aorta model with a perfusion 
pressure of 120 mmHg. All nine balloons that were tested were able to provide 
effective occlusion.  
When a 1 cm defect was cut in the iliac to simulate a traumatically damaged vessel, 
the balloon was able to fill the defect and continue on its proximal course to cause 
occlusion.   
Figure 4.19  Porcine aorta occluded at a perfusion pressure of 120 mmHg  
 
 
 
 
  
76 
Figure 4.20 Porcine aorta with iliac defect occlusion testing  
 
 
4.3.3 Discussion 
The device was shown to be able to occlude the flow of fluid through porcine blood 
vessels at a fluid pressure of 120 mmHg. Furthermore, when a 1 cm defect was cut 
into the iliac the balloon would fill that defect and continue its course up the vessel 
to cause more proximal occlusion.  This device has shown it can be used on a tissue 
model and can navigate a model of iliac injury.  By inflating to fill the defect in the 
blood vessel it will occlude flow out of that defect. The technique of inserting a Foley 
catheter into a junctional injury has already been used in trauma.  This device 
accomplishes a similar effect at the site of vessel injury with the added advantage of 
being able to continue more proximally to provide aortic occlusion. The next step is 
to show it  can be deployed in human anatomy. 
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4.4 PERFUSED HUMAN CADAVERIC TESTING 
4.4.1 Methods 
Human cadaver had a catheter inserted in their subclavian artery and was perfused 
with a water and red dye solution.  The cadaver was provided through the 
bequeathal program, Department of Anatomy & Cell Biology, Western University, 
London, Ontario, Canada, in accordance with the Anatomy Act of Ontario. These 
cadavers were never treated with formalin and were preserved by freezing until 
they were thawed for the experiments. The femoral arteries were dissected 
bilaterally. The device was deployed in the right common femoral artery (Figure 
4.21) and flow through the left femoral arteriotomy was observed for occlusion of 
flow. The cadavers were perfused to a pressure of 120 mmHg (Figure 4.22). 
 
4.4.2 Results 
The device was deployed in the right femoral artery. When it was deployed, flow 
through the arteriotomy in the left femoral artery stopped. 
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Figure 4.21 Device inserted into a human cadaver 
 
Figure 4.22 Occlusion of flow in a perfused human cadaver 
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4.4.3 Discussion 
This device has been tested on a perfused human cadaver model. It has shown that 
it can occlude flow of fluid in human blood vessels at a pressure of 120 mmHg.  It 
was deployed through a cut down and arteriotomy. It has not shown feasibility in a 
synthetic aorta, in porcine tissue vessels as well as perfused human vasculature. 
 
4.5 GENERAL DISCUSSION 
 
For a combat occlusion device to be feasible it would have to: be easy to use, have a 
short wire, be able to be transported with the patient, be able to manage blast 
injured pelvic vessels, and be able to tolerate contralateral iliac intubation. We have 
designed a novel device to meet these requirements.  
 
By having the wire internal to the balloon the problem of the guide-wire becoming 
extraluminal is alleviated. When advancing a wire through a damaged vessel it could 
exit the lumen and create a false passage. With this novel device the operator does 
not need to be a skilled endovascular surgeon navigating the wire to the perfect 
position before the device can be inserted; instead the balloon leads the way.  If the 
iliac vessel is injured preventing proximal navigation the balloon will inflate at that 
site of injury causing tamponade.  This is similar to the previously established 
technique of inflating a Foley catheter into a junctional injury for tamponade.  If the 
device could not be advanced because of iliac injury a second device could be 
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inserted into the contralateral side. If again it could not be advanced both can be left 
in place causing bilateral iliac tamponade and aiding in hemorrhage control.  This is 
superior to the tradition REBOA where if the wire cannot be safely advanced the 
technique must be aborted.   
 
One of the dangers of standard REBOA application is that the guide wire may 
descend down the contralateral iliac artery rather than advance into the aorta. If the 
REBOA balloon was then inserted and inflated in the contralateral iliac or femoral 
artery, rather than achieving aortic occlusion the procedure would cause further 
vascular trauma.  In the hands of skilled endovascular surgeons this complication 
may be reliably avoided however it is a real concern for forward application of this 
tool in combat medicine.  The advantage of this device is that if the balloon and its 
internal wire do go down the contralateral iliac, bilateral iliac occlusion is safely 
obtained as the balloon inflates up one limb and down the other (Figure 4.17).  This 
feature makes this novel device more suitable for a combat application.  The internal 
wire inside the balloon can help in gentle navigation and advancement and also be 
used to measure depth of balloon expansion without the challenges of classical 
Seldinger endovascular technique.  Since it is the balloon that gently leads the way 
the device will occlude as far as it travels rather than having to perfectly position a 
REBOA for deployment. 
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Figure 4.23 Balloon with contralateral limb intubation and bilateral occlusion 
 
Traditional REBOA balloons are inflated with saline, not CO2. Although a variant of 
this novel device can be produced with hydro-inflation, CO2 inflation has some 
advantages. The C02 cartridges are small and light and easily managed. The main 
advantage of water inflation is that it is essentially non-compressible. Once the 
balloon is inflated and occlusion is achieved the balloon will not be compressed as 
blood pressure is restored. With the CO2 inflated balloon as blood pressure 
increases the balloon will be compressed and it is possible that more CO2 will need 
to be put into the balloon.  However, this compressibility is advantageous when 
inflating the balloon in a damaged iliac. Rather than ripping apart the vessel with 
uncompressible expanding water balloon a gentler and softer compressible balloon 
fills the space of the defect while minimizing further destruction of the vessel. 
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Having a self-expanding water balloon advance down the iliac to the aorta would 
have a higher risk or vessel rupture. The compressibility of CO2 makes it perfect for 
this application. As has been demonstrated in our experiments occlusion of flow to 
supra-physiologic levels can still be achieved.   CO2 is also a good choice in the event 
of balloon rupture. This gas is rapidly absorbed and expelled though the lungs. This 
is the same reason for its use in laparoscopic surgery. Any gas embolism formed 
would be in the distal circulation and unlikely to cause cardiac or brain gas 
embolism. CO2 with its small sized containers, ease of use, compressibility and 
physiologic absorption make it an ideal choice for this device. 
 
This novel device has a wire that is only 30 cm in length which is much more easily 
handled than the 260 cm wires used in standard REBOA9. With the present design 
this device requires a short sheath to be inserted into the femoral artery. This is the 
same as with REBOA placement. During patient transport of the casualty, care must 
be taken not to disturb this sheath.  Although this novel device and REBOA share 
this challenge, the compact nature of the novel device and the short wire would 
make transporting the casualty simpler.  
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This novel aortic occlusion device has the advantage of having a shorter wire, being 
easier to transport with the patient, being able to provide occlusion to damaged iliac 
vessels, and can be inserted bilaterally. With further development and live animal 
testing this device may be able to be implemented in a forward environment to help 
combat casualties survive to the surgical care. 
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CHAPTER 5:  GENERAL DISCUSSION 
 
5.1 VASCULAR TRAUMA AND THE AP-IED 
Combat vascular trauma is the next area where military medical research can save 
lives.  Vascular procedures were the fourth most common performed in the 
Afghanistan and Iraq wars; however, they were the area in which there was the 
biggest change in practice over the course of the conflicts and greatest need for 
increased training and innovation.1,2 
 
The IED was the most common weapon to kill and injure Canadian soldiers in the 
Afghanistan war. 3 Through prospectively examining 100 consecutive IED victims 
we have provided a characterization and medical description of this weapons injury 
pattern.  The IED causes multiple amputation as well as pelvic fractures and 
significant perennial and gluteal injuries. Although tourniquets and pelvic binder 
have been very effective in saving the lives of the combat injured 4 if we are going to 
save even more soldiers lives we must develop strategies to control the non-
compressible hemorrhage caused by these weapons. 
5.2 PHYSICIANS AND LAND MINES 
War physicians played an integral role in the determination that the use of land mines is 
unethical.  Land mines are indiscriminate weapons. Unlike a rifle or rocket that is pointed 
at its target, a land mine is buried with the hopes that the enemy will detonate it.  But the 
enemy may not be the first person to step on it.  It may be a 12-year-old child or other 
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civilian.   When a conflict is over, the soldiers pointing their rifles and rockets leave; 
however, the land mine remains buried and remains equally as dangerous.  Once the war 
is over and all the soldiers have left, that 12-year-old child remains in danger from these 
weapons. 
The lack of discrimination and horrible wounds of land mines prompted the emergence of 
public campaigns for them to be banned. The work of advocates like Jody Williams, 
Bobby Muller, Princess Diana, and Lloyd Axworthy helped bring together 162 countries 
to sign The Convention on the Prohibition of the Use, Stockpiling, Production and 
Transfer of Anti-Personnel Mines and on their Destruction (the Ottawa Treaty) 5 in 
Ottawa, Canada in 1997. This was viewed as an international and Canadian success story. 
The International Campaign to Ban Landmines and Jody Williams were jointly awarded 
the Nobel Peace prize in 1997. 
What is less well-known are the contributions of Dr Robin Coupland and Dr Adriaan 
Korver to the anti-land mine effort. Prior to the publication of their work, surprisingly 
little attention had been paid to land mines in the medical literature.  Coupland and 
Korver described the injury patterns of antipersonnel land mines by reporting and 
analyzing the experience with land mines of 13 International Committee of the Red Cross 
Hospitals in Asia and Africa. They were able to develop a classification system for the 
pattern of land mine injuries and describe what land mines did to their victims 6-8.  Their 
work provided the medical foundation for the ethical debates surrounding the creation of 
the Ottawa Treaty, which would eventually lead to the banning of land mines by 162 
countries. They played a vital role in providing medically accurate and experiential 
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knowledge of the land mine’s impact on its victims and who the victims were.  Only a 
physician could have the requisite knowledge and experience to play that role. The 
contributions made by Coupland and Korver allowed Canada and the global community 
to make an informed decision.  
5.3 ETHICAL WAR AND THE LAW OF ARMED CONFLICT 
Although horrible suffering occurs during war, the global community has acknowledged 
that military necessity cannot be used to justify all violence. Customary Law based on 
global practices and principles had long existed; however, these laws of custom began to 
be codified as can be seen in the St Petersburg declaration in 1868 and the multiple 
Geneva and Hague Conventions. These were attempts to publicly declare what acts 
during war would be considered illegal.  War is not a lawless state of violence in which 
all actions are excused. People fighting wars are not exempt from ethics and the judgment 
of right and wrong.   The global community has accepted the concept of war crimes, and 
people engaging in wars cannot escape ethical and legal accountability. 
A prohibition of superfluous injury or unnecessary suffering is a cardinal principle of the 
International Court of Justice 9. The St Petersburg declaration, which was concerned with 
what weapons would be acceptable in combat, forbade “the employment of arms which 
uselessly aggravate the suffering of disabled men.10” This was reaffirmed in the Hague 
Conventions, which were some of the first attempts to codify what constituted a war 
crime.  The Hague Conventions specified that it was “prohibited to employ weapons, 
projectiles and material and methods of warfare of a nature to cause superfluous injury or 
unnecessary suffering.11” Whereas the St Petersburg Declaration and Hague Conventions 
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were defining what ammunition could be used and how wars were to be fought, the 
Geneva Conventions defined the humanitarian treatment of war.  Here again it was 
affirmed that “it is prohibited to employ weapons, projectiles and material and methods 
of warfare of a nature to cause superfluous injury or unnecessary suffering.12” Be it in 
treaties defining how wars should be fought, or in treaties outlining humanitarian 
treatment during war, it has been agreed upon time and again that superfluous injury or 
unnecessary suffering is illegal.  This prohibition is a part of customary law and 
applicable to all parties of any armed conflict 9.  Although it may be required in war to 
take a life, to intentionally make someone suffer beyond what is necessary to render him 
or her hors de combat is wrong. It is a crime. 
The horrible consequences of AP-IEDs were ubiquitous in the Afghanistan war. Anyone 
who buried one of these weapons would know the violence and injury they were 
inflicting on their victims. This knowledge speaks directly to the mental element, or mens 
rea, of their crime.  The users of these weapons knowingly mutilated their victim causing 
injuries far worse than would be required to incapacitate them.  The users of this weapon 
knew that it was indiscriminate and that civilians or children may be the victims. 
The application of unnecessary harm is not universalizable principle.  Neither side would 
want themselves to be tortured by their enemy.  Inflicting more injury than required for 
military victory shows no respect for the humanity of your enemy.   This is why the 
infliction of unnecessary suffering has been universally rejected in the global community. 
It fails both a utilitarian calculus and universal application of a deontological rule. There 
can be no reasonable ethic that would make it moral to inflict unnecessary suffering. 
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5.4 THE ILLEGALITY OF THE AP-IED 
It could be argued that the enemy in Afghanistan had no access to conventional weapons 
and, given the power and organization of the coalition soldiers, had to revert to using AP-
IEDs.  However, even if the objections of the indiscriminate nature of this weapon and 
the fact that it will persist beyond the conflict are overlooked, the fact that it has been 
designed to cause maximum harm is inexcusable.  They could have created a weapon 
similar to a land mine that caused foot or limb amputation and each of the soldiers injured 
in this way would be incapacitated and removed from the fight.  Instead they developed a 
weapon that would cause as much injury as possible. In making these weapons they 
chose to optimize the harm and damage they could produce. 
Whereas antipersonnel land mines cause amputation of the foot or leg resulting in the 
incapacitation of the victim, an AP-IED causes multiple amputations, perineal and genital 
mutilation, pelvic fractures and extensive soft tissue injury, and significant life long 
disability. The doctors who cared for casualties in Afghanistan routinely saw the 
destruction and devastation cause by these weapons, and like Coupland and Korver, they 
have captured and described the medical details of these patients. 13-16 The next step is to 
express moral outrage and protest against the use of these weapons in kind with Jody 
Williams, Bobby Muller, Princess Diana and Lloyd Axworthy.  Not only do AP-IEDs 
have the same indiscriminate harm of land mines, they cause superfluous injury and 
unnecessary suffering.  Improvised explosive devices are unethical weapons; their users 
have committed a war crime. 
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5.5 A NOVEL DEVICE 
IEDs cause multiple amputations and massive pelvic injury. REBOA has been proposed 
as a technique that can treat the non-compressible hemorrhage of the combat injured.  A 
gap analysis identified that as many as 18.5% of combat casualties might benefit from 
aortic occlusion. 17 Given that 98% of the coalition soldiers injured in Afghanistan 
survived if they could reach surgical care any device that could control hemorrhage until 
a patient can be evacuated to higher care would be of great help and likely save lives.18 
The REBOA technique has been used in combat and the patients did survive to be 
evacuated to a surgical facility.19 However, this was accomplished by having surgeons 
and emergentologists with extra endovascular training in a forward Special Forces 
environment.  This is not a feasible model for a broad military application.  If 
endovascular balloon occlusion of the aorta is going to save soldiers’ lives in wars like 
we just experienced in Afghanistan, General Duty Medical Officers with family 
residency training or Physicians Assistants will have to perform the procedures. If a 
practitioner is capable of placing a central line they can use this novel device. It has been 
designed expressly for combat application and it will make REBOA more accessible to 
forward military operations.  The novel device presented here does not require wire 
guidance, or x-ray confirmation of placement.  The balloon led technique can manage 
damaged iliac vessels and rapidly and easily provide aortic occlusion, stopping pelvic 
hemorrhage.  
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This device may also be useful in a civilian environment.  With centralization of vascular 
surgeons and clinicians in peripheral hospitals managing and treating fewer elective 
vascular surgeries, there has been a loss of skillset in the periphery.  Patients with 
significant vascular injuries are often rapidly evacuated to a tertiary center for definitive 
repair.  This novel device with its easy use and promise for navigating injured and 
perhaps calcified and aged vessels may have applications stopping hemorrhage for 
transport to definitive care. This new technology has the potential to save both military 
and civilian lives. 
5.6 VASCULAR INJURIES AT A CANADIAN CENTRE 
In order to better understand what vascular injuries are encountered in a civilian 
Canadian environment a retrospective five-year study was conducted. This demonstrated 
that vascular surgeons managed the majority of vascular injuries; however, surprisingly 
13 different specialties managed vascular injuries.  If there is to be change in the way that 
vascular surgery is managed, there must engagement with all of the multidisciplinary 
partners who manage these patients. 
There are potential areas for improvement in how vascular trauma was managed.  A 
damage control approach was taken in only one patient out of the 127 examined. The use 
of damage control techniques like aggressive ligation and temporary intravascular shunts 
may allow sick trauma patients to be able to get to the intensive care unit faster for 
correction of their physiologic derangements and then return later for definitive vascular 
repair. 
  
98 
There may be a population that would have benefited from the novel device.  There were 
29 patients with abdominal and pelvic vascular injuries. Some of these patients may have 
been able to have their bleeding controlled in the periphery or in the emergency room, 
decreasing their blood loss and physiologic derangement before getting to the operating 
room. As this new technology is further developed and its indications refined, the 
vascular trauma data collected here will be useful in identifying civilian populations 
worth considering for its application. 
5.7 FUTURE DIRECTIONS 
The three projects which comprise this work each have next steps to be taken. Next 
generation prototypes of the new device tested here need to be developed that can be 
inserted through a 7 or 8 Fr sheath.  This is feasible given that it has been shown to 
function in a catheter with an 8 Fr internal diameter. This size is important since its 
removal will not require repair of an arteriotomy and can be controlled with direct 
pressure.  This prototype should be tested on animal models demonstrating its 
physiologic effects and safety profile as the next step before eventual human application.  
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The Canadian vascular trauma research registry is going to be applied to multiple centers.  
At present four other Canadian level 1 trauma centers are in the progress of collecting the 
same retrospective data over the same time period.  This will allow for a more robust 
description of the Canadian vascular trauma experience that can be compared to 
American registries.20 It will also allow for intra-Canadian comparison to be done and for 
the establishment of a Canadian vascular trauma research network.  If this work proves to 
be fruitful, a prospective Canadian vascular trauma registry could be established. 
There is now a medical description of the injury pattern of the AP-IED and it is much 
more serious and devastating than that of the APM. In this instance the next steps are less 
of a scientific and more of an ethical and societal nature. Armed with the medical 
knowledge of what and AP-IED can do, the medical community and society at large 
should oppose the use of these weapons much as they did in opposition to the use of 
landmines. 
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